LITH Stock Overview
Operates in cannabinoid market. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BioELife Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.000001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -99.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| LITH | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.6% |
| 1Y | n/a | 14.2% | 32.3% |
Return vs Industry: Insufficient data to determine how LITH performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how LITH performed against the US Market.
Price Volatility
| LITH volatility | |
|---|---|
| LITH Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LITH's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine LITH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Greg Rotelli | www.bioelife.com |
BioELife Corp. operates in cannabinoid market. It offers cannabinoid products, such as combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls, and flowers. The company was formerly known as US Lithium Corp. and changed its name to BioELife Corp. in March 2020.
BioELife Corp. Fundamentals Summary
| LITH fundamental statistics | |
|---|---|
| Market cap | US$9.00 |
| Earnings (TTM) | -US$589.69k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs LITH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LITH income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$800.00 |
| Gross Profit | -US$800.00 |
| Other Expenses | US$588.89k |
| Earnings | -US$589.69k |
Last Reported Earnings
Sep 30, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did LITH perform over the long term?
See historical performance and comparison